Seliciclib Recruiting Phase 2 Trials for Cushings Disease Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02160730Treatment of Cushing's Disease With R-roscovitine